List of Excipients in API bremelanotide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing bremelanotide
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
AMAG Pharmaceuticals Inc | VYLEESI | bremelanotide | 64011-701 | GLYCERIN | 2024-06-21 |
AMAG Pharmaceuticals Inc | VYLEESI | bremelanotide | 64011-701 | HYDROCHLORIC ACID | 2024-06-21 |
AMAG Pharmaceuticals Inc | VYLEESI | bremelanotide | 64011-701 | SODIUM HYDROXIDE | 2024-06-21 |
AMAG Pharmaceuticals Inc | VYLEESI | bremelanotide | 64011-701 | WATER | 2024-06-21 |
Palatin Technologies | VYLEESI | bremelanotide | 80064-141 | GLYCERIN | 2024-06-21 |
Palatin Technologies | VYLEESI | bremelanotide | 80064-141 | HYDROCHLORIC ACID | 2024-06-21 |
Palatin Technologies | VYLEESI | bremelanotide | 80064-141 | SODIUM HYDROXIDE | 2024-06-21 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for bremelanotide
Excipient focus: GLYCERIN
bremelanotide drug variants containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
AMAG Pharmaceuticals Inc | bremelanotide | 64011-701 |
Palatin Technologies | bremelanotide | 80064-141 |
>Company | >Ingredient | >NDC |
bremelanotide drug variants not containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
bremelanotide drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
AMAG Pharmaceuticals Inc | bremelanotide | 64011-701 |
Palatin Technologies | bremelanotide | 80064-141 |
>Company | >Ingredient | >NDC |
bremelanotide drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
bremelanotide drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
AMAG Pharmaceuticals Inc | bremelanotide | 64011-701 |
Palatin Technologies | bremelanotide | 80064-141 |
>Company | >Ingredient | >NDC |
bremelanotide drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
bremelanotide drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
AMAG Pharmaceuticals Inc | bremelanotide | 64011-701 |
Palatin Technologies | bremelanotide | 80064-141 |
>Company | >Ingredient | >NDC |
bremelanotide drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.